Vicebio Ltd
https://www.vicebio.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Vicebio Ltd
Finance Watch: Vicebio Adds To 2024’s Mega-Round Total With $100m Series B
Private Company Edition: Vicebio plans to take a combo vaccine into Phase I with its $100m series B venture capital round. Also, Nura Bio raised $68m to boost its series A total to $141m and George Church-founded GC Therapeutics launched with $75m, among other recent VC deals.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice